Literature DB >> 3668519

Failure to detect dopamine receptor IgG autoantibodies in sera of schizophrenic patients. Short note.

A von Kirchbach1, E G Fischer, H H Kornhuber.   

Abstract

Autoantibodies against dopamine receptors in schizophrenic patients have been postulated. IgG was fractionated from sera of 15 schizophrenic patients (DSM III) in an acute episode. However, 3H-spiperone binding to dopamine receptors was not inhibited by this fraction.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3668519     DOI： 10.1007/bf01252518

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  21 in total

1.  Immunoglobulins, psychopathology and prognosis in schizophrenia.

Authors:  E Pulkkinen
Journal:  Acta Psychiatr Scand       Date:  1977-09       Impact factor: 6.392

2.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Authors:  I Creese; D R Burt; S H Snyder
Journal:  Science       Date:  1976-04-30       Impact factor: 47.728

Review 3.  Is schizophrenia a viral or immunologic disorder?

Authors:  L E DeLisi; T J Crow
Journal:  Psychiatr Clin North Am       Date:  1986-03

4.  Are there antibodies against brain in sera from schizophrenic patients? Review and prospectus.

Authors:  L E DeLisi; R J Weber; C B Pert
Journal:  Biol Psychiatry       Date:  1985-01       Impact factor: 13.382

5.  [Disorder of the blood-brain barrier in schizophrenia].

Authors:  J Kornhuber; K Bauer
Journal:  Dtsch Med Wochenschr       Date:  1986-06-27       Impact factor: 0.628

6.  Dopamine-receptor-stimulating autoantibodies: a possible cause of schizophrenia.

Authors:  J G Knight
Journal:  Lancet       Date:  1982-11-13       Impact factor: 79.321

7.  Altered white cell count, protein concentration and oligoclonal IgG bands in the cerebrospinal fluid of many patients with acute psychiatric disorders.

Authors:  A Ahokas; M L Koskiniemi; A Vaheri; R Rimón
Journal:  Neuropsychobiology       Date:  1985       Impact factor: 2.328

8.  Quantitative determination of immunoglobulins in CSF and plasma of chronic schizophrenic patients.

Authors:  L E Delisi; D R Weinberger; S Potkin; L M Neckers; D J Shiling; R J Wyatt
Journal:  Br J Psychiatry       Date:  1981-12       Impact factor: 9.319

9.  Automimmune response to dopamine-receptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia.

Authors:  O Abramsky; Y Litvin
Journal:  Perspect Biol Med       Date:  1978       Impact factor: 1.416

10.  Autoimmune model of schizophrenia with special reference to antibrain antibodies.

Authors:  R S Pandey; A K Gupta; U C Chaturvedi
Journal:  Biol Psychiatry       Date:  1981-12       Impact factor: 13.382
View more
  3 in total

1.  Autoantibodies to brain and polynucleotides in patients with schizophrenia: a puzzle.

Authors:  H A Teplizki; B Sela; Y Shoenfeld
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 2.  Antineuronal antibodies against neurotransmitter receptors and synaptic proteins in schizophrenia: current knowledge and clinical implications.

Authors:  Johann Steiner; Kolja Schiltz; Hans-Gert Bernstein; Bernhard Bogerts
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

3.  HLA DRB1*03 as a possible common etiology of schizophrenia, Graves' disease, and type 2 diabetes.

Authors:  Aicha Sayeh; Cheker Ben Cheikh; Ali Mardessi; Meriem Mrad; Brahim Nsiri; Abdelaziz Oumaya; Najiba Fekih-Mrissa
Journal:  Ann Gen Psychiatry       Date:  2017-02-02       Impact factor: 3.455
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.